ANT-GROUP
Ant Group (or “the Company”) today released its 2023 Sustainability Report, showcasing the Company’s significant progress since the introduction of its ESG strategy in 2022 and demonstrating its commitment to transparency and to its sustainable business practices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240612743798/en/
Technological Innovation (Graphic: Business Wire)
The report highlights noteworthy advancements across key areas, underpinned by four core pillars: Technological Innovation, Digital Inclusion, Green and Low-Carbon Development, and Open Ecosystem.
“Looking ahead, we are constantly reflecting on how to stay true to our original aspirations in this era of rapid change, continuously bringing about more small yet beautiful changes to the world,” said Eric Jing, Chairman & CEO of Ant Group. “Since our journey started from Alipay’s inception in 2004, technology-driven innovation has always been the fundamental force propelling our growth. It will play an even greater role in shaping our future.”
Technological Innovation
To drive innovation for consumers, small and micro-sized enterprises (SMEs) and partners, Ant Group has increased its investment in technology R&D for three consecutive years, reaching a record high of RMB 21.19 billion yuan (~ 2.92 billion USD) in 2023. Ant Group’s BaiLing Foundation Model, which was approved to serve the Chinese public in 2023, has been powering AI assistants that make it easier for users to access various life services on the Alipay platform, from smart life assistant, to smart healthcare manager and smart financial manager.
Digital Inclusion
By leveraging digital payment and finance innovation, Ant Group, together with its associate MYbank, have served more than 87 million SMEs as of 2023.
On the Alipay platform, thousands of Independent Software Vendors (ISVs) have developed more than 700 digital solutions for 4.27 million merchants, enabling them to seize more business opportunities through digital operations. In 2023, the annual transaction volume of merchant operated Alipay mini-programs grew by 68% year-on-year.
Green and Low-Carbon Development
By the end of 2023, Ant Group had achieved operation-wide carbon neutrality for three consecutive years, with a 43.19% reduction in absolute Scope 1 & 2 emissions compared to the 2020 baseline year. In accordance with standards such as the "Greenhouse Gas Protocol: Corporate Value Chain (Scope 3) Accounting and Reporting Standards" and the "Global Financial Industry Greenhouse Gas Accounting and Reporting Standards," Ant Group conducted the Company’s first comprehensive accounting for Scope 3 carbon emissions in 2023, covering 11 categories related to activities along Ant Group's value chain, which provides a scientific basis for further emission reduction initiatives.
Since its launch in 2016, Alipay Ant Forest has encouraged more than 690 million users to make everyday low-carbon choices. As a result, 475 million trees have been planted by local partners with financial support from the Company.
Open Ecosystem
To better connect travelers with merchants and facilitate cross-border commerce, more than 25 leading e-wallets and banking apps have adopted Alipay+, a suite of cross-border digital payment and digitalization technology solutions. Alipay+ enables their users to pay and travel like locals, bringing international businesses to over 88 million merchants worldwide. In addition, with its one World Account, WorldFirst has served one million SME traders to pay, connect, and manage money globally.
The 10x1000 Tech for Inclusion program has provided exchange and learning opportunities for 6,243 certified learners from over 100 countries and regions, of whom nearly half are women participants.
Ant Group, after establishing 19 sustainability issues with 3-year OKRs (Objectives and Key Results) and plans in 2022, has upgraded its governance and incentive system in line with global best practices. This includes linking senior management’s remuneration to the Company’s risk management and sustainability performance metrics.
In 2023, Ant Group used relevant Sustainability Accounting Standards Board(SASB) industry standards as a guiding reference for its sustainability reporting for the first time. Ant Group also bolstered its climate-related disclosures with reference to the International Sustainability Standards Board (ISSB) requirements, including detailing how its executives and senior management tackle climate-related decisions as well as the establishment of an early warning platform to monitor extreme weather's impact on business operations.
Note: All figures are as of December 31, 2023 unless otherwise specified. The 2023 Sustainability Report is available in Chinese. The English-language version will be available on Ant Group’s official website soon.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240612743798/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis13.12.2024 23:09:00 CET | Press release
Ad hoc announcement pursuant to Art. 53 LR Approximately 7% of people in the United States (U.S.) have atopic dermatitis – a common, chronic, and flaring inflammatory skin disease, characterized by persistent itch and recurrent skin lesions1-4 While currently available treatments may improve some signs and symptoms of the disease, many patients do not respond optimally to approved therapies and do not experience itch relief and clear skin to the same degree2,5-7 Nemluvio® (nemolizumab) is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31. IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and epidermal dysregulation in atopic dermatitis2,9-11 This approval follows Nemluvio’s recent approval for the treatment of adults with prurigo nodularis from the U.S. Food and Drug Administration earlier in August 202412 Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug
Andersen Global forstærker sin dækning af Asien-Stillehavsregionen med ejendomsrådgivere i Australien13.12.2024 19:39:00 CET | Pressemeddelelse
Andersen Global styrker sin platform i Asien og Stillehavsregionen gennem en samarbejdsaftale med Charter Keck Cramer, der er et af Australiens førende, uafhængige ejendomsrådgivningsfirmaer. Det, der i 1970 begyndte som en lille virksomhed, Charter Keck Cramer, har siden udviklet sig til et tværfagligt firma med mere end 170 eksperter, der er fordelt på fem kontorer i Australien og Singapore. Firmaet tilbyder et omfattende udvalg af ejendomsrelaterede ydelser, herunder værdiansættelser inden for bolig- og erhvervsejendomme, ejendoms- og udviklingsrådgivning, ejendomsdata og analyser samt strategisk planlægning og byøkonomi samt kvantitetsopmåling. Charter Keck Cramer betjener en mangfoldig australsk og international kundebase, herunder offentlige og private virksomheder, ejere og udviklere, større banker og finansielle institutioner, institutionelle ejere og truster, statslige organer og familiekontorer. "Vores vækst over de seneste 54 år er drevet af vores uafhængige, skræddersyede t
Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks13.12.2024 15:00:00 CET | Press release
Businesses Must Employ a Multi-Layered Approach to Fight GenAI Fraud Today, Experian announced its 2024 Global Identity & Fraud Report that provides a comprehensive view of the consumer and business response to the latest fraud patterns and fraud‑mitigation strategies in the worldwide financial services sector. The report offers combined insights from more than 1,000 businesses and fraud leaders globally, as well as 4,000 consumers, focusing on fraud management and the digital experience. Among its key insights, the report casts a bright spotlight on three factors driving the fast-evolving fraud landscape: the huge growth in Generative Artificial Intelligence (GenAI) technologies, changing government regulations, and the push among businesses to provide consumers with secure and convenient digital experiences. In response to these factors, the report’s findings revealed that businesses intend to increase fraud budgets driven by investments in AI and machine learning technologies. “Unli
Capcom Announces Onimusha Way of the Sword, Marking the First New Title in the Series in Over 20 Years! Work on an Okami Sequel Project Begins!13.12.2024 14:00:00 CET | Press release
Capcom Co., Ltd. (TOKYO:9697) today announced that Onimusha Way of the Sword, the first new title in the Onimusha series in over 20 years, is scheduled to be released, while work on an Okami sequel project has also started. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241213232085/en/ Onimusha Way of the Sword (Graphic: Business Wire) The Onimusha series consists of swordplay action games where players assume the role of warriors with the superhuman powers of the Oni and fight against monsters bent on world domination. Onimusha Way of the Sword, scheduled to be released globally in 2026, is a Japanese-inspired dark fantasy game set at the beginning of the Edo period in Kyoto, which has been eerily transformed by clouds of Malice. In the game, the samurai protagonist is equipped with the Oni Gauntlet and engages in epic sword battles with the grotesque and otherworldly creatures known as Genma. Capcom hopes that players loo
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell13.12.2024 13:51:00 CET | Press release
BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing agreement to advance BrightPath’s novel allogeneic CAR-T cell therapy platform, utilizing iPSC-derived NKT cells for clinical trials. The strategic collaboration includes the use of Cellistic's innovative 3D bioreactor-based manufacturing platform, Echo, to enable GMP-compliant, clinical-scale manufacturing of iPSC-derived BCMA-targeting CAR-NKT cells for Phase 1 multiple myeloma trial; establishing BrightPath as a first mover in this emerging field. “The use of NKT cells as effectors in allogeneic CAR-T therapy represents a promising strategy, offering not only direct cytotoxicity but also indirect anti-tumor activity through the priming of host CD8+ T cells—a mechanism expected to evade host immune rejection and to enhance the dur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom